Integrated Nano-Trojan Horse Protocol for Restoring Cellular Communication in Solid Tumors: A Disruptive Conceptual Framework

Background: Solid tumors present formidable therapeutic challenges due to metabolic reprogramming (Warburg effect) and disrupted intercellular communication networks. Conventional cytolytic approaches often fail to address foundational mechanisms of tumor autonomy. Objective: This conceptual paper introduces a novel integrative framework---Nano-Enabled Communication Restoration (NECR)---merging insulin-targeted nanotechnology with near-infrared (NIR)-activated immunomodulation to restore disrupted cellular communication in solid tumors. Methods: We propose a unified mathematical framework with explicit model hierarchy: (1) baseline growth dynamics (Gompertz, logistic, von Bertalanffy); (2) spatial invasion and transport (Fisher-KPP, advection-diffusion); (3) vascular-tumor coupling (Hahnfeldt extension); and (4) treatment-integrated stochastic core. The NECR protocol employs insulin-conjugated nanoparticles (20--100\,nm, zeta potential -10 to +10\,mV pH-switchable) as Trojan horses to deliver ECM-restorative enzymes and NIR-sensitive modulators. Treatment effects are explicitly incorporated via receptor-limited drug kinetics, pH-triggered release (Henderson-Hasselbalch), photobiomodulation terms, and immune reactivation components. Synthetic data validation follows TCGA-BRCA distributions with hierarchical Bayesian uncertainty quantification and global Sobol sensitivity analysis. Results: Monte Carlo simulations ($n=100$ runs) predict 96--99.8\% tumor reduction at days 40--100 under NECR versus untreated controls ($p<10^{-15}$, Cliff's $\delta=0.98$; see Table~\ref{tab:results} and Figure~\ref{fig:comparative}). Global sensitivity identifies drug efficacy ($\alpha$) and NIR potency ($\beta$) as dominant parameters (total Sobol indices: 0.68, 0.51; Table~\ref{tab:sensitivity}), supporting targeted optimization. Mechanistic coupling equations quantitatively link molecular events (IR-A binding, ROS generation, Cx43 upregulation) to tissue-level outcomes (carrying capacity reduction, immune surveillance restoration; Figure~\ref{fig:mechanistic_coupling}). Conclusions: NECR offers a theoretically rigorous, mechanistically grounded framework for remission induction through nano-light synergy. While experimental validation remains pending, the enhanced mathematical formalism, comprehensive parameterization (Table~\ref{tab:parameters}), and proposed verification roadmap (Figure~\ref{fig:roadmap}) provide a robust foundation for translational development. All derivations, code (Appendix~\ref{app:code}), and synthetic datasets are provided for reproducibility. Keywords: Cancer therapy; Nanotechnology; Cellular communication; NIR photobiomodulation; Mathematical modeling; Tumor angiogenesis; Bayesian inference; Synthetic data validation